TY  - JOUR
AU  - Rockwood, Kenneth
AU  - Sanon Aigbogun, Myrlene
AU  - Stanley, Justin
AU  - Wong, Helen
AU  - Dunn, Taylor
AU  - Chapman, Chère A T
AU  - Howlett, Susan E
AU  - Miguelez, Maia
AU  - McGarrigle, Lisa
AU  - Baker, Ross A
PY  - 2019
DA  - 2019/06/28
TI  - The Symptoms Targeted for Monitoring in a Web-Based Tracking Tool by Caregivers of People With Dementia and Agitation: Cross-Sectional Study
JO  - J Med Internet Res
SP  - e13360
VL  - 21
IS  - 6
KW  - Alzheimer disease
KW  - dementia
KW  - agitation
KW  - neuropsychiatric symptoms
KW  - internet
KW  - caregiver
AB  - Background: In people with dementia, neuropsychiatric symptoms (NPSs), especially agitation, are associated with worse quality of life and caregiver burden. As NPSs may vary with illness severity, knowledge of how people with dementia and their caregivers describe and rate the importance of agitation symptoms can improve the understanding of the clinical meaningfulness of the manifestations of agitation. The internet provides new opportunities to better understand patient experiences, as patients and caregivers increasingly look to Web-based platforms as a means of managing symptoms. Objective: The aim of this study was to examine Web-based reports from a dementia symptom website to better understand the symptoms of agitation and explore how they are being targeted for monitoring by caregivers of people with dementia. Methods: The Dementia Guide website hosts a Web-based database used by caregivers (97%) and people with dementia (3%). From its 61 dementia symptoms, users can select relevant symptoms that they deem important to monitor or track the effects of treatment. We employed a staging algorithm to determine if individuals had mild cognitive impairment (MCI) or mild, moderate, or severe dementia. Agitation was defined using terms consistent with the International Psychogeriatrics Association’s provisional consensus definition. We compared the proportion of people with NPSs and agitation across stages of dementia severity and studied how many agitation-defining descriptors were selected, and how often they occurred, by stage. Results: As of March 2017, 4121 people had used the tracking tool, of whom 2577 provided sufficient data to allow disease severity staging. NPSs were tracked by 2127/2577 (82.54%) and agitation by 1898/2577 (73.65%). The proportion in whom agitation was tracked increased with increasing cognitive impairment: 68.5% (491/717) in people with MCI, and 72.50% (754/1040), 73.3% (378/516), and 90.5% (275/304) in mild, moderate, and severe dementia, respectively (χ23=54.9; P<.001). The number of NPS and agitation descriptors selected also increased with severity (median number of NPSs=1, 2, 2, and 3 for MCI, mild, moderate, and severe dementia, respectively, Kruskal-Wallis H Test H3=250.47; P<.001; median number of agitation descriptors=1, 2, 3, and 4, H3=146.11; P<.001). Conclusions: NPSs and agitation are common targets for tracking over the course of dementia and appear more frequently with increasing disease severity. These common and distressing symptoms represent clinically meaningful targets in treating people with dementia. 
SN  - 1438-8871
UR  - https://www.jmir.org/2019/6/e13360/
UR  - https://doi.org/10.2196/13360
UR  - http://www.ncbi.nlm.nih.gov/pubmed/31254339
DO  - 10.2196/13360
ID  - info:doi/10.2196/13360
ER  -